Reducing the Risk of Adverse Drug Events in Older Adults



FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.


FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

Am Fam Physician. 2013 Mar 1;87(5):331-336.

  Patient information: See related handout on adverse drug events in older adults, written by the authors of this article.

This version of the article contains supplemental content.

Adverse drug events occur in 15 percent or more of older patients presenting to offices, hospitals, and extended care facilities. These events are potentially preventable up to 50 percent of the time. Common serious manifestations include falls, orthostatic hypotension, heart failure, and delirium. The most common causes of death are gastrointestinal or intracranial bleeding and renal failure. Antithrombotic and antidiabetic medications, diuretics, and nonsteroidal anti-inflammatory drugs cause most of the preventable hospital admissions due to adverse drug events. Strategies to reduce the risk of adverse drug events include discontinuing medications, prescribing new medications sparingly, reducing the number of prescribers, and frequently reconciling medications. The Beers, STOPP (screening tool of older persons' potentially inappropriate prescriptions), and START (screening tool to alert doctors to right treatment) criteria can help identify medications causing adverse drug events. Not all potentially inappropriate medications can be avoided. Clinicians should involve patients in shared decision making and individualize prescribing decisions based on medical, functional, and social conditions; quality of life; and prognosis.

The effects of medications in older adults are not often studied adequately, even though more than one-half of all prescription medications are dispensed to persons older than 60 years.1 More than 90 percent of noninstitutionalized older adults in the United States take at least one prescription medication,2 and those who are seen in the office take six to eight medications on average.35

One in six hospital admissions of older adults is because of an adverse drug event,6 a proportion that is four times that of younger persons. For persons older than 75 years, hospital admissions because of an adverse drug event increase even further to one in three.7,8 While in the hospital, one in six older patients experiences an adverse drug event.9 In the office and community settings, one in five older adults is taking potentially inappropriate medications.3,5,10

There are five categories of adverse drug events: adverse drug reaction, medication error, therapeutic failure, adverse drug withdrawal event, and overdose.11 Adverse drug reactions are the most common, accounting for three-fourths of hospitalizations from adverse drug events; the remainder are caused by nonadherence, or omission or cessation of treatment.7 The World Health Organization further identifies adverse drug events as unintended and undesired effects of a medication at the normal dose; therapeutic failures, overdoses, and medication abuse are excluded.6,12

Reducing the risk of adverse drug events in older adults requires close monitoring of functional status, early identification of symptoms, and recognition of the impact a medication can have on multiple organ systems. Because of the many variables that must be considered in caring for older adults, clinical judgment is paramount.

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendation Evidence rating References

The use of antipsychotics, antidepressants, benzodiazepines, and sedative/hypnotics in older adults should be limited to reduce the risk of falls.

C

31

The number of medications in older adults should be limited, because each new medication adds more than one adverse drug event each year and taking six or more medications increases this risk fourfold.

C

3, 4, 30

Ideally, the primary care physician should prescribe all medications, because each additional prescriber increases the risk of adverse drug events in older adults by 30 percent.

C

33

Patients with several chronic health conditions should be asked often about adverse drug events, because the odds of an event double for four or five conditions and triple for six or more.

C

33


A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to http://www.aafp.org/afpsort.xml.

SORT: KEY RECOMMENDATIONS FOR PRACTICE

View Table

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendation Evidence rating References

The use of antipsychotics, antidepressants, benzodiazepines, and sedative/hypnotics in older adults should be limited to reduce the risk of falls.

C

31

The number of medications in older adults should be limited, because each new medication adds more than one adverse drug event each year and taking six or more medications increases this risk fourfold.

C

3, 4, 30

Ideally, the primary care physician should prescribe all medications, because each additional prescriber increases the risk of adverse drug events in older adults by 30 percent.

C

33

Patients with several chronic health conditions should be asked often about adverse drug events, because the odds of an event double for four or five conditions and triple for six or more.

C

33


A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to http://www.aafp.org/afpsort.xml.

Pharmacokinetics

Physiologic changes in older adults increase the risk of harm from medications metabolized by the liver and kidneys. Hepatic blood flow decreases by nearly one-half (40 percent) in older adults,13 and some degree of chronic kidney disease is present in one-half of older adults.14 Furthermore, median renal blood flow decreases by one-half by the time patients reach 80 years of age, although the individual rate of decline varies and one-third of older adults maintain normal renal function.15 Heart failure, which affects more than 40 percent of persons older than 80 years, can further reduce function of the aging kidneys and liver.16

Other factors influence pharmacokinetics in older adults. Aging decreases first-pass clearance in the liver, and a number of commonly prescribed medications (e.g., warfarin [Coumadin], benzodiazepines, opiates) require much lower doses in older adults. Distribution of drugs to body compartments is changed by the decrease in the ratio of lean body weight to body fat. Levels of serum proteins, which bind many drugs, decrease in older adults because of malnutrition and dietary changes that are common for both intentional (e.g., lifestyle changes) and unintentional reasons (e.g., dentures, altered appetites, changes in food preparers, comorbidities, dietary restrictions). Drug metabolism can be affected by substance abuse, including alcohol; up to 10 percent of older adults are heavy or problem drinkers.17

Sources of Adverse Drug Events

Overall, 30 percent of adverse drug events in the outpatient setting are potentially preventable18 (Table 110,1925), and some studies have shown that more than one-half of hospital admissions for adverse drug events are preventable.7 A systematic review of nine international studies attributed most preventable medication-related admissions to antithrombotic medications, diuretics, and nonsteroidal anti-inflammatory drugs.24 In another study, two-thirds of all medication-related admissions to the hospital involved antithrombotic and antidiabetic medications, almost always by unintentional overdose.26 In a prospective study of 1,225 hospital admissions related to adverse drug events, 20 of 28 deaths were due to gastrointestinal or intracranial bleeding and five were due to renal failure.27

Table 1.

Medications to Avoid When Possible in Older Adults

Medication Comment References

Antipsychotic use for longer than one month

Most common potentially inappropriate type of medication used in nursing homes

19

Nonsteroidal anti-inflammatory drug use for longer than three months

One of the three most common potentially inappropriate medications used in nursing homes

19,20

3 percent of older adults are using this medication for this duration at the time of hospital admission

Proton pump inhibitor use at maximum therapeutic dosage for longer than eight weeks

One of the three most common potentially inappropriate medications used in nursing homes

19,20

Most common potentially inappropriate medication being used at the time of hospital admission (21 percent of hospitalized older adults)

Aspirin in patients with no history of coronary, cerebral, or peripheral vascular symptoms or arterial occlusive events

11 percent of older adults are taking aspirin under these circumstances at the time of hospital admission

20

Benzodiazepines in patients who have had at least one fall in the past three months

9 percent of older adults are using this potentially inappropriate medication under this circumstance at the time of hospital admission

20

Duplicate drug class prescriptions

9 percent of older adults are using two medications from the same drug class at the time of hospital admission

20

Long-acting benzodiazepine or benzodiazepine with long-acting metabolites use for longer than one month

8 percent of older adults are using this medication for this duration at the time of hospital admission

20

Loop diuretic as first-line monotherapy for hypertension

4 percent of older adults are using this medication for this reason at the time of hospital admission

20

Proton pump inhibitors, long-acting benzodiazepines, nonsteroidal anti-inflammatory drugs, nonselective beta blockers, and tricyclic antidepressants

These five categories of medications caused nearly 80 percent of the inappropriate prescribing detected by the STOPP criteria in the outpatient setting

10

Haloperidol

Although long-term use of antipsychotics should be avoided, haloperidol doubled the risk of death when newly prescribed for older adults in nursing homes (hazard ratio = 2.07 compared with risperidone [Risperdal])

21

Quetiapine (Seroquel) should be considered (hazard ratio = 0.81)

Megestrol (Megace) and sliding-scale insulin

Added to the 2012 Beers criteria

22

Selective serotonin reuptake inhibitors

Increased fall risk (odds ratio = 1.72) even more than tricyclic antidepressants (odds ratio = 1.51)

23

Sulfonylureas

Glyburide added to the 2012 Beers criteria

22


note: Medications are listed in order of highest to lowest prevalence of potentially inappropriate use in older adults. Medications prescribed for common indications that are not avoidable (e.g., antithrombotic and antidiabetic medications) should be carefully reviewed for indications, compliance, and monitoring.24,25

STOPP = screening tool of older persons' potentially inappropriate prescriptions.

Information from references 10, and 19 through 25.

Table 1.   Medications to Avoid When Possible in Older Adults

View Table

Table 1.

Medications to Avoid When Possible in Older Adults

Medication Comment References

Antipsychotic use for longer than one month

Most common potentially inappropriate type of medication used in nursing homes

19

Nonsteroidal anti-inflammatory drug use for longer than three months

One of the three most common potentially inappropriate medications used in nursing homes

19,20

3 percent of older adults are using this medication for this duration at the time of hospital admission

Proton pump inhibitor use at maximum therapeutic dosage for longer than eight weeks

One of the three most common potentially inappropriate medications used in nursing homes

19,20

Most common potentially inappropriate medication being used at the time of hospital admission (21 percent of hospitalized older adults)

Aspirin in patients with no history of coronary, cerebral, or peripheral vascular symptoms or arterial occlusive events

11 percent of older adults are taking aspirin under these circumstances at the time of hospital admission

20

Benzodiazepines in patients who have had at least one fall in the past three months

9 percent of older adults are using this potentially inappropriate medication under this circumstance at the time of hospital admission

20

Duplicate drug class prescriptions

9 percent of older adults are using two medications from the same drug class at the time of hospital admission

20

Long-acting benzodiazepine or benzodiazepine with long-acting metabolites use for longer than one month

8 percent of older adults are using this medication for this duration at the time of hospital admission

20

Loop diuretic as first-line monotherapy for hypertension

4 percent of older adults are using this medication for this reason at the time of hospital admission

20

Proton pump inhibitors, long-acting benzodiazepines, nonsteroidal anti-inflammatory drugs, nonselective beta blockers, and tricyclic antidepressants

These five categories of medications caused nearly 80 percent of the inappropriate prescribing detected by the STOPP criteria in the outpatient setting

10

Haloperidol

Although long-term use of antipsychotics should be avoided, haloperidol doubled the risk of death when newly prescribed for older adults in nursing homes (hazard ratio = 2.07 compared with risperidone [Risperdal])

21

Quetiapine (Seroquel) should be considered (hazard ratio = 0.81)

Megestrol (Megace) and sliding-scale insulin

Added to the 2012 Beers criteria

22

Selective serotonin reuptake inhibitors

Increased fall risk (odds ratio = 1.72) even more than tricyclic antidepressants (odds ratio = 1.51)

23

Sulfonylureas

Glyburide added to the 2012 Beers criteria

22


note: Medications are listed in order of highest to lowest prevalence of potentially inappropriate use in older adults. Medications prescribed for common indications that are not avoidable (e.g., antithrombotic and antidiabetic medications) should be carefully reviewed for indications, compliance, and monitoring.24,25

STOPP = screening tool of older persons' potentially inappropriate prescriptions.

Information from references 10, and 19 through 25.

Alternative medications can cause adverse drug events as well. The U.S. public spent $14.8 billion on nonvitamin, nonmineral, and natural products in 2007, which is equivalent to one-third of the total out-of-pocket spending on prescription medications.28 The rate of use of over-the-counter medications is threefold higher in older adults compared with younger adults, and the use of herbal preparations is twofold higher.29

A Systematic Approach

A systematic approach for detecting adverse drug events should be used at all visits, including comprehensive visits and any visits in which news and symptoms are present. Additional time should be allocated for this purpose during visits with older adults. Table 2 lists recommendations for assessing older patients for adverse drug events.3,4,25,30 Common serious manifestations of adverse drug events, which should prompt an immediate review of the medication list, are falls and orthostatic hypotension (24 percent), heart failure (17 percent), and delirium (15 percent).7 Because older adults with orthostatic hypotension are up to eight times more likely to experience an adverse drug event,4 blood pressure and heart rate should be measured in the supine and standing positions in older patients, particularly those who fall or have cardiovascular symptoms. The use of antipsychotics, antidepressants, benzodiazepines, and sedative/hypnotics in older adults should be limited to reduce the risk of falls.31

Table 2.

Practical Recommendations for Assessing Older Patients for Adverse Drug Events

Diagnosing and managing an adverse drug event in an older patient requires:

An understanding of the physiology of aging

An awareness of the most common causes of adverse drug events

A high index of suspicion in all patients (especially those with a history of adverse drug events and/or nonadherence; with cognitive impairment, psychiatric disease, or substance abuse; and those who live alone)

Time to examine the older adult, review medications with the patient/caregiver, provide education about altering drug therapy, and review printed medication information

Suspicion for an adverse drug event should be heightened in patients:

With a change in function (activities of daily living, instrumental activities of daily living), including change in mental status, falls, or hospital admission

With new symptoms after starting a new medication or changing the dosage of a current medication

Taking more than four medications


Information from references 3, 4, 25, and 30.

Table 2.   Practical Recommendations for Assessing Older Patients for Adverse Drug Events

View Table

Table 2.

Practical Recommendations for Assessing Older Patients for Adverse Drug Events

Diagnosing and managing an adverse drug event in an older patient requires:

An understanding of the physiology of aging

An awareness of the most common causes of adverse drug events

A high index of suspicion in all patients (especially those with a history of adverse drug events and/or nonadherence; with cognitive impairment, psychiatric disease, or substance abuse; and those who live alone)

Time to examine the older adult, review medications with the patient/caregiver, provide education about altering drug therapy, and review printed medication information

Suspicion for an adverse drug event should be heightened in patients:

With a change in function (activities of daily living, instrumental activities of daily living), including change in mental status, falls, or hospital admission

With new symptoms after starting a new medication or changing the dosage of a current medication

Taking more than four medications


Information from references 3, 4, 25, and 30.

When prescribing medications in older adults, the old maxim “start low and go slow” still applies (Table 3).2,5,18,23,30 Identifying the quality-of-life outcomes most valued by the patient should take precedence over the routine implementation of practice guidelines that recommend medications for generic clinical scenarios. Carefully considering the patient's priorities before taking any action is often the critical first step in reducing the risk of adverse drug events. Likewise, clinicians should avoid the tendency to treat every symptom with a medication, particularly because the symptom in question may be the adverse effect of another medication. In some cases, the best strategy is to avoid prescribing new medications altogether, because each new medication adds more than one additional adverse drug event per year.30 Taking six or more medications increases this risk fourfold.3

Table 3.

Practical Considerations to Reduce the Risk of Adverse Drug Events in Older Adults

Be watchful for medications started at a younger age that have never been adjusted for patient aging or changes in renal and hepatic function.

Medications required in the short-term setting (e.g., hospital) are often not needed in the long-term setting, or they can be used at a much lower dose. The dose for a loop diuretic, for instance, may need to be increased fourfold or more in the hospital setting, yet the baseline dose is often sufficient once the acute crisis has passed.

Avoid adding medications to treat an adverse effect of another medication. The preferred options are to decrease the dose, discontinue the medication, or, if necessary, change to a different medication.

Ask about self-medication with over-the-counter and herbal medications, which can interact with prescribed medications.

Do not automatically increase the dose of a medication because of a subtherapeutic level or suboptimal response without first verifying adherence to therapy.

Identifying an adverse drug event in older adults may be difficult because of atypical presentations or because the symptoms are being attributed to the disease; for example, altered mental status may be attributed to dementia, delirium, or forgetfulness when prescribed medications are the true cause.

When prescribing medications, use those with a wide therapeutic window.

Review medication lists regularly and reconcile them to the patient's problem list to discontinue duplicate therapies, adjust doses and dosing frequency, and discontinue unnecessary medications (i.e., issue is no longer a problem).

Set an end date and use objective criteria to determine the success or failure of an empiric trial and act accordingly. Do not continue these medications, particularly those used for pain, behavior, and cognition, indefinitely.

“Start low and go slow” in dosing new medications.

Set up regular visits (e.g., every two to four weeks), including appropriate laboratory testing, to monitor medication use in patients with multiple comorbidities.

Avoid starting two new medications in the same patient at the same time.

Regularly use a standardized method to review patient medications (e.g., the Beers, STOPP, and START criteria), including when the patient has a change in function (sentinel event) or problems with his or her medication.


START = screening tool to alert doctors to right treatment; STOPP = screening tool of older persons' potentially inappropriate prescriptions.

Information from references 2, 5, 18, 23, and 30.

Table 3.   Practical Considerations to Reduce the Risk of Adverse Drug Events in Older Adults

View Table

Table 3.

Practical Considerations to Reduce the Risk of Adverse Drug Events in Older Adults

Be watchful for medications started at a younger age that have never been adjusted for patient aging or changes in renal and hepatic function.

Medications required in the short-term setting (e.g., hospital) are often not needed in the long-term setting, or they can be used at a much lower dose. The dose for a loop diuretic, for instance, may need to be increased fourfold or more in the hospital setting, yet the baseline dose is often sufficient once the acute crisis has passed.

Avoid adding medications to treat an adverse effect of another medication. The preferred options are to decrease the dose, discontinue the medication, or, if necessary, change to a different medication.

Ask about self-medication with over-the-counter and herbal medications, which can interact with prescribed medications.

Do not automatically increase the dose of a medication because of a subtherapeutic level or suboptimal response without first verifying adherence to therapy.

Identifying an adverse drug event in older adults may be difficult because of atypical presentations or because the symptoms are being attributed to the disease; for example, altered mental status may be attributed to dementia, delirium, or forgetfulness when prescribed medications are the true cause.

When prescribing medications, use those with a wide therapeutic window.

Review medication lists regularly and reconcile them to the patient's problem list to discontinue duplicate therapies, adjust doses and dosing frequency, and discontinue unnecessary medications (i.e., issue is no longer a problem).

Set an end date and use objective criteria to determine the success or failure of an empiric trial and act accordingly. Do not continue these medications, particularly those used for pain, behavior, and cognition, indefinitely.

“Start low and go slow” in dosing new medications.

Set up regular visits (e.g., every two to four weeks), including appropriate laboratory testing, to monitor medication use in patients with multiple comorbidities.

Avoid starting two new medications in the same patient at the same time.

Regularly use a standardized method to review patient medications (e.g., the Beers, STOPP, and START criteria), including when the patient has a change in function (sentinel event) or problems with his or her medication.


START = screening tool to alert doctors to right treatment; STOPP = screening tool of older persons' potentially inappropriate prescriptions.

Information from references 2, 5, 18, 23, and 30.

In addition to close medical follow-up (e.g., scheduling the next appointment in two to four weeks) when prescribing new medications, the physician should encourage self-monitoring by informing the patient of the time frame in which any potential adverse drug events may occur. Empiric medication trials, such as those of dementia medications, should include a target date when effectiveness and potential adverse reactions will be reviewed. Stopping medications can significantly decrease fall risk.32 Because multiple prescribers increase the number of adverse drug events (each additional prescriber increases the risk of adverse drug events by 30 percent),33 consultants should be asked to make recommendations to the primary care physician, rather than prescribe directly.

What an older patient actually takes on a daily basis may be different from what has been prescribed or what the patient says he or she is taking. Because the medication list is the “problem list” in many cases, medication reconciliation should occur at every visit, including vitamins and over-the-counter and herbal medications. This is sometimes referred to as the “brown bag check” in the office setting and the “cupboard check” at a home visit. If discrepancies emerge, pharmacies should be contacted to verify medications and the frequency with which they have been filled, because one-third of medication-related hospital admissions are due to patient adherence problems.24 Other third parties, including emergency medical personnel, family members, visiting home nurses, and extended care facility personnel, may be queried if possible. Patients with several chronic health conditions require further investigation, because the odds of an adverse drug event double for four or five conditions and triple for six or more.33

Clinical Tools

BEERS CRITERIA

The Beers criteria are the most commonly used criteria to assist clinicians in preventing adverse drug events in older adults.22,34 Since their inception more than two decades ago, the Beers criteria have been revised three times, most recently in 2012 by an expert panel sponsored by the American Geriatrics Society. They are comprised of two comprehensive lists of medications to be avoided in older adults, one list independent of diagnosis and the other considering the diagnosis. A third list contains medications to be used with caution.22 New additions to the list of medications to be avoided in older adults include megestrol (Megace), glyburide, and sliding-scale insulin.22 Acetylcholinesterase inhibitors should be avoided in patients with syncope because of the risk of bradycardia.22 Similarly, glitazones should be avoided in patients with heart failure, and selective serotonin reuptake inhibitors should be avoided in patients with falls and fractures.22,23 The Beers criteria are accessible on the American Geriatrics Society website at http://www.americangeriatrics.org. They also can be printed as a pocket card and downloaded as a smartphone app.

Several limitations of the Beers criteria are that some relevant medications are missing and others could be taken off the list; they include some therapeutic duplications; and they do not address common drug-drug interactions. A systematic review found an association between use of medications listed in the Beers criteria and hospitalization in community-dwelling older adults35; however, data are limited to suggest that using the Beers criteria to manage medications in patients decreases mortality, improves quality of life, or reduces the use of resources.8

STOPP AND START CRITERIA

Potentially inappropriate medications, defined by the validated STOPP (screening tool of older persons' potentially inappropriate prescriptions) criteria, are significantly associated with avoidable adverse drug events that cause or contribute to urgent hospitalization in older persons.20  The STOPP criteria are comprised of 65 clinically significant criteria for potentially inappropriate prescribing in older persons. Each criterion is accompanied by a brief explanation about why the prescribing practice is potentially inappropriate. The STOPP criteria represent the more common avoidable instances of inappropriate prescribing in older persons in day-to-day clinical practice. Although the STOPP and Beers criteria overlap (eTable A), each set detects potentially inappropriate medications that the other does not. More importantly, the STOPP and Beers criteria are not comprehensive, and a number of older adults are admitted to hospitals with adverse drug events from medications that are not identified by either.25

Table A.

Using Clinical Tools to Detect Potentially Inappropriate Medications

Case example: An 85-year-old white woman with metabolic syndrome and heart failure comes to the office for a new patient appointment. She also has a history of seizures, anxiety, depression, and alcoholism. She weighs 110 lb (50 kg) and has a serum creatinine level of 1.0 mg per dL (88.4 μmol per L).
Current medications for case example Clinical tools Comments
Beers criteriaA1 STOPP criteriaA2

Alprazolam (Xanax), 1 mg orally three times daily

Avoid benzodiazepines (any type) for treatment of insomnia, agitation, and delirium

All benzodiazepines increase the risk of falls, fracture, cognitive impairment, delirium, and motor vehicle crashes in older adults

Potentially inappropriate to use long-acting benzodiazepines (e.g., chlordiazepoxide [Librium], flurazepam, clorazepate) and benzodiazepines with long-acting metabolites (e.g., diazepam [Valium]) for longer than one month because of the risk of prolonged sedation, confusion, impaired balance, and falls

Also potentially inappropriate to use benzodiazepines in patients who fall, because the sedative may cause reduced sensorium and impair balance

Because of significantly increased risk of falls in older adults, benzodiazepines should be weaned and discontinued

Amlodipine (Norvasc), 10 mg orally daily

Not listed

Potentially inappropriate to use calcium channel blockers in patients with chronic constipation, because they may exacerbate constipation

Decrease dosage or discontinue if the patient's blood pressure is adequately controlled with lisinopril and hydrochlorothiazide

Aspirin, 81 mg orally daily

Avoid aspirin dosage greater than 325 mg daily

May exacerbate existing ulcers or cause new or additional ulcers

Avoid use in patients with history of peptic ulcer disease unless other alternatives are not effective and patient can take gastroprotective agents (proton pump inhibitor or misoprostol [Cytotec])

Potentially inappropriate to use aspirin in certain circumstances, including in dosages greater than 150 mg daily; in patients with a history of peptic ulcer disease without a histamine H2 antagonist or proton pump inhibitor; and in patients without a history of coronary, cerebral, or peripheral vascular symptoms or arterial occlusive event (not indicated)

Aspirin can be appropriate in patients with well-controlled hypertension and target organ damage, diabetes mellitus, or atrial fibrillation

Although aspirin meets the Beers and STOPP criteria for use in this patient, data are limited in persons 80 years and older. The potential benefit due to a reduction in myocardial infarction and ischemic stroke should be balanced with the risk of gastrointestinal or intracranial bleeding and falls

Cinnamon bark, two 600-mg capsules orally three times daily with meals

Herbal medications not addressed

Herbal medications not addressed

Consider discontinuing because it decreases serum glucose levels and increases risk of hypoglycemia

Garlic, 400 mg orally three times daily

Herbal medications not addressed

Herbal medications not addressed

Consider discontinuing because it interacts with aspirin and can increase risk of bleeding

Glyburide, 5 mg orally twice daily

Long-duration sulfonylureas should be avoided

Glyburide has a higher risk of severe prolonged hypoglycemia in older adults

Not listed

Consider discontinuing because of the high risk of hypoglycemia

Hydrochlorothiazide, 25 mg orally daily

Diuretics not listed

Potentially inappropriate to use thiazide diuretics in patients with a history of gout, because they may exacerbate gout

Lower dose often effective

Monitor potassium levels and renal function

Lisinopril (Zestril), 40 mg orally daily

Use in patients with syncope should be avoided to prevent increasing the risk of orthostatic hypotension or bradycardia

Potentially inappropriate to use angiotensin-converting enzyme inhibitors when optimization of monotherapy within a single drug class has not been observed before considering a new class of drug

Consider decreasing dosage because the patient's creatinine clearance is 32 mL per minute per 1.73 m2 (0.53 mL per second per m2) based on the Cockcroft-Gault equation*

Dose range of 2.5 to 10 mg daily often used in older adults

Metformin (Glucophage), 1,000 mg orally twice daily

Not listed

Not listed

Decrease dosage to 500 mg twice daily because of the patient's age and history of heart failure

Although the patient's serum creatinine level is less than 1.4 mg per dL (123.76 μmol per L), creatinine clearance is 32 mL per minute per 1.73 m2, which will increase the risk of acidosis

Phenytoin (Dilantin), 100 mg orally three times daily

Not listed

Not listed

Consider stopping because indication may no longer exist

Consider obtaining a free phenytoin level because hypoalbuminemia is common in older adults and phenytoin is highly protein bound

Simvastatin (Zocor), 80 mg daily

Statins not listed

Not listed

Consider decreasing or discontinuing because of uncertain benefit in older adults and association with memory lossA3

The U.S. Food and Drug Administration recommends maximum dosage of 40 mg daily in adults

Tramadol (Ultram), 50 mg orally every six hours as needed

Avoid Lowers seizure threshold

Not listed

Decrease dosage or discontinue because of the effects of age and alcoholism on liver function

Tramadol also causes constipation in older adults prone to constipation and small bowel obstructions

Zolpidem (Ambien), 10 mg at bedtime as needed

Avoid long-term use (more than 90 days) because of adverse central nervous system effects

Adverse effects include delirium, falls, and fractures

Minimal improvement in sleep latency and duration

Not listed

Decrease dosage or discontinue because of increased risk of dependency in older adults


STOPP = screening tool of older persons' potentially inappropriate prescriptions.

*— For women:

For men:

Information from:

A1. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–631.

A2. Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP (screening tool of older person's prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.

A3. Evans MA, Golomb BA. Statin-associated adverse cognitive effects: survey results from 171 patients. Pharmacotherapy. 2009;29(7):800–811.

Table A.   Using Clinical Tools to Detect Potentially Inappropriate Medications

View Table

Table A.

Using Clinical Tools to Detect Potentially Inappropriate Medications

Case example: An 85-year-old white woman with metabolic syndrome and heart failure comes to the office for a new patient appointment. She also has a history of seizures, anxiety, depression, and alcoholism. She weighs 110 lb (50 kg) and has a serum creatinine level of 1.0 mg per dL (88.4 μmol per L).
Current medications for case example Clinical tools Comments
Beers criteriaA1 STOPP criteriaA2

Alprazolam (Xanax), 1 mg orally three times daily

Avoid benzodiazepines (any type) for treatment of insomnia, agitation, and delirium

All benzodiazepines increase the risk of falls, fracture, cognitive impairment, delirium, and motor vehicle crashes in older adults

Potentially inappropriate to use long-acting benzodiazepines (e.g., chlordiazepoxide [Librium], flurazepam, clorazepate) and benzodiazepines with long-acting metabolites (e.g., diazepam [Valium]) for longer than one month because of the risk of prolonged sedation, confusion, impaired balance, and falls

Also potentially inappropriate to use benzodiazepines in patients who fall, because the sedative may cause reduced sensorium and impair balance

Because of significantly increased risk of falls in older adults, benzodiazepines should be weaned and discontinued

Amlodipine (Norvasc), 10 mg orally daily

Not listed

Potentially inappropriate to use calcium channel blockers in patients with chronic constipation, because they may exacerbate constipation

Decrease dosage or discontinue if the patient's blood pressure is adequately controlled with lisinopril and hydrochlorothiazide

Aspirin, 81 mg orally daily

Avoid aspirin dosage greater than 325 mg daily

May exacerbate existing ulcers or cause new or additional ulcers

Avoid use in patients with history of peptic ulcer disease unless other alternatives are not effective and patient can take gastroprotective agents (proton pump inhibitor or misoprostol [Cytotec])

Potentially inappropriate to use aspirin in certain circumstances, including in dosages greater than 150 mg daily; in patients with a history of peptic ulcer disease without a histamine H2 antagonist or proton pump inhibitor; and in patients without a history of coronary, cerebral, or peripheral vascular symptoms or arterial occlusive event (not indicated)

Aspirin can be appropriate in patients with well-controlled hypertension and target organ damage, diabetes mellitus, or atrial fibrillation

Although aspirin meets the Beers and STOPP criteria for use in this patient, data are limited in persons 80 years and older. The potential benefit due to a reduction in myocardial infarction and ischemic stroke should be balanced with the risk of gastrointestinal or intracranial bleeding and falls

Cinnamon bark, two 600-mg capsules orally three times daily with meals

Herbal medications not addressed

Herbal medications not addressed

Consider discontinuing because it decreases serum glucose levels and increases risk of hypoglycemia

Garlic, 400 mg orally three times daily

Herbal medications not addressed

Herbal medications not addressed

Consider discontinuing because it interacts with aspirin and can increase risk of bleeding

Glyburide, 5 mg orally twice daily

Long-duration sulfonylureas should be avoided

Glyburide has a higher risk of severe prolonged hypoglycemia in older adults

Not listed

Consider discontinuing because of the high risk of hypoglycemia

Hydrochlorothiazide, 25 mg orally daily

Diuretics not listed

Potentially inappropriate to use thiazide diuretics in patients with a history of gout, because they may exacerbate gout

Lower dose often effective

Monitor potassium levels and renal function

Lisinopril (Zestril), 40 mg orally daily

Use in patients with syncope should be avoided to prevent increasing the risk of orthostatic hypotension or bradycardia

Potentially inappropriate to use angiotensin-converting enzyme inhibitors when optimization of monotherapy within a single drug class has not been observed before considering a new class of drug

Consider decreasing dosage because the patient's creatinine clearance is 32 mL per minute per 1.73 m2 (0.53 mL per second per m2) based on the Cockcroft-Gault equation*

Dose range of 2.5 to 10 mg daily often used in older adults

Metformin (Glucophage), 1,000 mg orally twice daily

Not listed

Not listed

Decrease dosage to 500 mg twice daily because of the patient's age and history of heart failure

Although the patient's serum creatinine level is less than 1.4 mg per dL (123.76 μmol per L), creatinine clearance is 32 mL per minute per 1.73 m2, which will increase the risk of acidosis

Phenytoin (Dilantin), 100 mg orally three times daily

Not listed

Not listed

Consider stopping because indication may no longer exist

Consider obtaining a free phenytoin level because hypoalbuminemia is common in older adults and phenytoin is highly protein bound

Simvastatin (Zocor), 80 mg daily

Statins not listed

Not listed

Consider decreasing or discontinuing because of uncertain benefit in older adults and association with memory lossA3

The U.S. Food and Drug Administration recommends maximum dosage of 40 mg daily in adults

Tramadol (Ultram), 50 mg orally every six hours as needed

Avoid Lowers seizure threshold

Not listed

Decrease dosage or discontinue because of the effects of age and alcoholism on liver function

Tramadol also causes constipation in older adults prone to constipation and small bowel obstructions

Zolpidem (Ambien), 10 mg at bedtime as needed

Avoid long-term use (more than 90 days) because of adverse central nervous system effects

Adverse effects include delirium, falls, and fractures

Minimal improvement in sleep latency and duration

Not listed

Decrease dosage or discontinue because of increased risk of dependency in older adults


STOPP = screening tool of older persons' potentially inappropriate prescriptions.

*— For women:

For men:

Information from:

A1. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–631.

A2. Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP (screening tool of older person's prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.

A3. Evans MA, Golomb BA. Statin-associated adverse cognitive effects: survey results from 171 patients. Pharmacotherapy. 2009;29(7):800–811.

The STOPP criteria are designed to be used in tandem with the START (screening tool to alert doctors to right treatment) criteria. Both are available at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810806/.10 The START criteria have been validated in the same fashion as the STOPP criteria and represent the more common instances of inappropriate omission of potentially beneficial medications. The START criteria consist of 22 evidence-based prescribing indicators for commonly encountered diseases in older persons. More research is needed to know whether routine application of the STOPP, START, and Beers criteria leads to meaningful clinical benefits and significant reductions in health care utilization.25

A number of free and low-cost software systems identify potential drug-drug interactions. Improving the design and content of tools, such as the STOPP, START, and Beers criteria, and incorporating them into electronic prescribing systems can lead to improved sensitivity and greater clinician acceptance while improving specificity of the electronic system with less “alert fatigue” and fewer overrides by clinicians.20

Criteria for potentially inappropriate medications are not meant to replace clinical judgment; rather, they are designed to decrease adverse drug events and improve medical treatment of older patients. Not all potentially inappropriate medications can be avoided, especially when clinicians and patients agree that the benefits of a medication outweigh the risks. Therefore, prescribing decisions should be individualized based on medical, functional, and social conditions; quality of life; and prognosis, and should involve shared decision making.

Data Sources: Scopus and PubMed were searched using the key words elderly, geriatrics, older adult, adverse drug events, and adverse drug reactions. Additional searches were done in the Cochrane database, Agency for Healthcare Research and Quality Clinical Guidelines and Evidence Reports, U.S. Preventive Services Task Force, Bandolier, the Institute for Clinical Systems Improvement, and Essential Evidence Plus. Search date: October 2011 to March 2012.

The Authors

RICHARD W. PRETORIUS, MD, MPH, is a professor of geriatrics and of family medicine, and an assistant dean for quality and primary care research at the Wright State University Boonshoft School of Medicine in Dayton, Ohio.

GORDANA GATARIC, MD, is an assistant professor of geriatrics and of internal medicine at the Wright State University Boonshoft School of Medicine.

STEVEN K. SWEDLUND, MD, is an assistant professor of geriatrics and of family medicine, and director of the geriatric medicine fellowship at the Wright State University Boonshoft School of Medicine.

JOHN R. MILLER, RPh, is an associate professor of family medicine at the Wright State University Boonshoft School of Medicine, and an assistant clinical professor at the Ohio Northern University Raabe College of Pharmacy in Ada.

Address correspondence to Richard W. Pretorius, MD, MPH, 725 University Blvd., Dayton, OH 45435-0001. (e-mail: richard.pretorius@wright.edu). Reprints are not available from the authors.

Author disclosure: No relevant financial affiliations.

The authors thank Larry W. Lawhorne, MD, for his editing assistance, and Bette S. Sydelko, MSLS, MEd, for her research and manuscript development assistance.

REFERENCES

1. Tangiisuran B, Gozzoli MP, Davies JG, Rajkumar C. Adverse drug reactions in older people. Rev Clin Gerontol. 2010;20(3):246–259.

2. Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc. 2004;52(8):1349–1354.

3. Buck MD, Atreja A, Brunker CP, et al. Potentially inappropriate medication prescribing in outpatient practices: prevalence and patient characteristics based on electronic health records. Am J Geriatr Pharmacother. 2009;7(2):84–92.

4. Chan DC, Chen JH, Kuo HK, et al. Drug-related problems (DRPs) identified from geriatric medication safety review clinics. Arch Gerontol Geriatr. 2012;54(1):168–174.

5. Chrischilles E, Rubenstein L, Van Gilder R, Voelker M, Wright K, Wallace R. Risk factors for adverse drug events in older adults with mobility limitations in the community setting. J Am Geriatr Soc. 2007;55(1):29–34.

6. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;24(2):46–54.

7. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J. 2001;31(4):199–205.

8. Page RL II, Ruscin JM. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmacother. 2006;4(4):297–305.

9. Tangiisuran B, Wright J, Van der Cammen T, Rajkumar C. Adverse drug reactions in elderly: challenges in identification and improving preventative strategies. Age Ageing. 2009;38(4):358–359.

10. Ryan C, O'Mahony D, Kennedy J, Weedle P, Byrne S. Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol. 2009;68(6):936–947.

11. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140(10):795–801.

12. World Health Organization. Medicines: safety of medicines–adverse drug reactions. http://www.who.int/mediacentre/factsheets/fs293/en/index.html. Accessed January 10, 2013.

13. Le Couteur DG, McLean AJ. The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clin Pharmacokinet. 1998;34(5):359–373.

14. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol. 2003;14(7 suppl 2):S131–S138.

15. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33(4):278–285.

16. Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol. 2000;35(6):1628–1637.

17. Adams WL, Cox NS. Epidemiology of problem drinking among elderly people. Int J Addict. 1995;30(13–14):1693–1716.

18. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107–1116.

19. Parsons C, Johnston S, Mathie E, et al. Potentially inappropriate prescribing in older people with dementia in care homes: a retrospective analysis. Drugs Aging. 2012;29(2):143–155.

20. Hamilton H, Gallagher P, Ryan C, Byrne S, O'Mahony D. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011;171(11):1013–1019.

21. Huybrechts KF, Gerhard T, Crystal S, et al. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ. 2012;344:e977.

22. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–631.

23. Boyle N, Naganathan V, Cumming RG. Medication and falls: risk and optimization. Clin Geriatr Med. 2010;26(4):583–605.

24. Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2006;63(2):136–147.

25. Vishwas HN, Harugeri A, Parthasarathi G, Ramesh M. Potentially inappropriate medication use in Indian elderly: comparison of Beers' criteria and screening tool of older persons' potentially inappropriate prescriptions. Geriatr Gerontol Int. 2012;12(3):506–514.

26. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002–2012.

27. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15–19.

28. Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl HealthStat Report. 2009;(18):1–14.

29. Batty GM, Oborne CA, Swift CG, Jackson SH. The use of over-the-counter medication by elderly medical in-patients. Postgrad Med J. 1997;73(865):720–722.

30. Steinman MA, Lund BC, Miao Y, Boscardin WJ, Kaboli PJ. Geriatric conditions, medication use, and risk of adverse drug events in a predominantly male, older veteran population. J Am Geriatr Soc. 2011;59(4):615–621.

31. Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons [published correction appears in Arch Intern Med. 2010;170(5):477]. Arch Intern Med. 2009;169(21):1952–1960.

32. van der Velde N, Stricker BH, Pols HA, van der Cammen TJ. Risk of falls after withdrawal of fall-risk-increasing drugs: a prospective cohort study. Br J Clin Pharmacol. 2007;63(2):232–237.

33. Green JL, Hawley JN, Rask KJ. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother. 2007;5(1):31–39.

34. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC; UCLA Division of Geriatric Medicine. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151(9):1825–1832.

35. Jano E, Aparasu RR. Healthcare outcomes associated with Beers' criteria: a systematic review. Ann Pharmacother. 2007;41(3):438–447.


Copyright © 2013 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Download PDF
  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

More in Pubmed

Navigate this Article